Scaffold in Emilia Romagna and in the MAGIC Network
SHERPA-MAGIC
Scaffold Implantation in Emilia-Romagna Plus Multi Absorbable Gears Intra Coronary
1 other identifier
observational
1,111
1 country
17
Brief Summary
The prospective study will investigate the clinical performance and long-term safety of scaffold implantation in a real world regional setting. The protocol includes two different networks. The first network includes all cath-labs in the Emilia-Romagna region (SHERPA). The second includes the centers partecipating into the MAGIC retrospective study. Both networks joined into the prospective SHERPA-MAGIC project. Investigators from both networks agreed in indications and strategy implanatation described by the protocol. In each center, after IRB approval, the patients will be enrolled according to established criteria.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2017
Longer than P75 for all trials
17 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 27, 2017
CompletedFirst Posted
Study publicly available on registry
November 1, 2017
CompletedStudy Start
First participant enrolled
December 2, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2034
May 1, 2026
April 1, 2026
12.1 years
October 27, 2017
April 27, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Device Oriented Cardiac Events
cumulative occurence of cardiovascular death, target vessel myocardial infarction and target vessel revascularization. Target is defined the vessel treated with scaffold
1 year
Study Arms (1)
scaffold
Patients receiving during PCI the implantation of at least one scaffold
Interventions
Eligibility Criteria
Patients with symptomatic coronary artery disease needing the treatment of de novo native coronary artery lesions.
You may qualify if:
- subjects \>18 years
- sign of the patients informed consent
- implanation of at least one scaffold
You may not qualify if:
- inability to garantuee at least one year follow-up
- inabiliuty to garantuee at least one year compliance to dual antiplatelet regimen
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (17)
AO San Giovanni di Dio
Agrigento, Agrigento, Italy
Ospedale Caravaggio-Treviglio
Treviglio, Bergamo, Italy
Azienda Ospedaliera Universitaria di Bologna
Bologna, Bologna, Italy
U.O. Cardiologia, Ospedale Maggiore
Bologna, Bologna, Italy
Ospedale SS Annunziata
Savigliano, Cuneo, Italy
University Hospital of Ferrara
Cona, Ferrara, 44124, Italy
U.O. Cardiologia, Ospedale Morgagni Pierantoni
Forlì, Forlì-Cesena, Italy
U.O. Cardiologia, Azienda Ospedaliera Universitaria di Modena, Policlinico
Modena, Modena, Italy
U.O. Cardiologia, Ospedale di Baggiovara
Modena, Modena, Italy
U.O. di Cardiologia, Azienda Ospedaliero-Universitaria di Parma
Parma, Parma, Italy
Ospedale Guglielmo da Saliceto
Piacenza, Piacenza, Italy
Maria Cecilia Hospital - GVM Care & Research
Cotignola, Ravenna, Italy
U.O. di Cardiologia, Ospedale Santa Maria delle Croci
Ravenna, Ravenna, Italy
U.O. di Cardiologia, Ospedale degli Infermi
Rimini, Rimini, Italy
AOU San Luigi Gonzaga
Orbassano, Torino, Italy
Ospedale di Rivoli
Rivoli, Torino, Italy
Ospedale di Sanremo
Sanremo, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 27, 2017
First Posted
November 1, 2017
Study Start
December 2, 2017
Primary Completion (Estimated)
December 31, 2029
Study Completion (Estimated)
December 31, 2034
Last Updated
May 1, 2026
Record last verified: 2026-04